Amgen Inc. (AMGN)
Amgen (AMGN) Ascends While Market Falls: Some Facts to Note
Amgen (AMGN) concluded the recent trading session at $331.29, signifying a +0.1% move from its prior day's close.
3 Biotech Stocks to Buy Now: Q3 Edition
Biotech stocks to buy can be an interesting sector for investors. They can provide massive gains following positive news regarding clinical trials or FDA approvals.
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
What Is the Dividend Payout for Amgen Stock?
Amgen currently continues its pattern of quarterly dividend increases. Furthermore, Amgen demonstrated product-sales growth in the first quarter.
Amgen (AMGN) Rises Higher Than Market: Key Facts
Amgen (AMGN) reachead $330.83 at the closing of the latest trading day, reflecting a +1.77% change compared to its last close.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
‘Crash proof' your portfolio with these 10 stocks and 3 ETFs
You don't get upset for having homeowner's insurance but your house doesn't burn down. The same principle should apply to investors who insure their stock portfolios against a crash.
3 Dividend Stocks Crushing the S&P 500 With 30%+ Annual Total Returns
With technology-driven growth stocks propelling the S&P 500 to new heights, dividend stocks have often found themselves playing catch-up. Yet, even in this market environment, some dividend-paying companies have managed not only to keep pace, but also beat the index by a significant margin.
Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Amgen shares have outperformed IBB by over 40% in the past year, driven higher by a major surge post-earnings in May. With a current price-to-earnings multiple in the mid-teens, I assert that solid and consistent EPS growth ahead warrants a higher valuation. AMGN's chart is also impressive, with a long-term uptrend in place.
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
Amgen is much cheaper than Eli Lilly. Vertex Pharmaceuticals has several major growth drivers.
1 Dividend Growth Stock to Buy and Hold for 10 Years
Amgen has maintained an impressive dividend streak over the past decade. The company's business should allow it to maintain this momentum for a while.
Jefferies Red-Hot Summer Top Stock Picks Include 5 Blue Chip Dividend Giants
24/7 Wall St. Insights Jefferies is one of Wall Street's fastest-growing firms.
